Additionally, Lys17, upon further modification (e.g., K26 in Semaglutide), is expected to enhance the binding affinity of SR18 to serum albumin (Supplementary Figure S2), improving its in vivo pharmacological functions
If both are being used primarily for weight loss, your prescriber may discuss whether combination therapy is necessary or whether optimising one medication first would be more appropriate
Sobo provides physician-guided GLP-1 weight loss care through Optimal Health Medical in Stamford, CT, with personalized treatment planning, medical screening, dosing guidance, progress monitoring, and long-term weight maintenance support
Response from the owner: Thank you Emily
Everyone starts on a low dose and slowly increases